Join the Acute Coronary Syndrome group to help and get support from people like you.
Acute Coronary Syndrome News (Page 2)
FDA Approves Expanded Indication for Brilinta to Include Long-Term Use in Patients with a History of Heart Attack
Thursday, 3 September 2015 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Brilinta (ticagrelor) tablets at a new 60mg dose to be used in patients with a...
Medicure Announces Approval of Expanded Dosing Time For Aggrastat
WINNIPEG, April 23, 2015 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, is pleased to announce that the United States Food and...
FDA Approves New Crushing Option for the Administration of Brilinta
March 30, 2015 – AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are...
FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes
July 20, 2011 - The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary...